Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of Tiscover for chronic ulcers in long-term care residents
NL-OMON30845Withdrawn
- Sponsor
- Vrije University Medical Center
- Start
- Mar 2007
- Modality
- Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label trial of Tiscover in stasis ulcer, diabetic foot ulcer (DFU), decubitus ulcer and 2 more (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Percent decrease of ulcer. Planned start Mar 2007; status: withdrawn.
02
Drugs
Tiscover
03
Conditions
stasis ulcerdiabetic foot ulcer (DFU)decubitus ulcerarterial ulcerchronic ulcer
Beyond the preview
Go deeper on NL-OMON30845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30845.